CD8A and cancer: IFN γ released from immunotherapy-actived CD8+ T promotes ferroptosis in tumor cells by decreasing the expression of SLC3A2 and SLC7A11, which is instrumental in boosting the efficacy of cancer immunotherapy (Wang et al., 2019).